CHRISTINE BAUGH: Open Payments
NPI 1104946656 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$506 in 18 payments from 12 companies in 2025. Trend: 2023 $363 · 2024 $566 · 2025 $506
Food & beverage: $506
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $124 |
| Calliditas Therapeutics US Inc. | 2 | $61 |
| Fresenius USA Marketing, Inc. | 3 | $59 |
| Lilly USA, LLC | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Apellis Pharmaceuticals, Inc. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Ardelyx, Inc. | 1 | $25 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: Ozempic, TARPEYO, VELPHORO, JARDIANCE, JYNARQUE, Fabhalta, IBSRELA, ULTOMIRIS.
Industry payments across CO — which companies pay providers there.
